Life Sciences
The Emerging Role of Optical Genome Mapping in Immunotherapy Research
Join us for an installment of our Bionano In Motion webinar series as our speakers delve into immunotherapies and the emerging role of optical genome mapping…
Broadcast Date: September 6, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Join us for an installment of our Bionano In Motion webinar series as our speakers delve into immunotherapies and the emerging role of optical genome mapping (OGM) in assessing genome integrity as part of CAR-T cell therapy research.
In this webinar, Dr. Alex Hastie, VP of Clinical and Scientific Affairs at Bionano, will provide an introduction on the utility of OGM in cell and gene therapy. Dr. Rashmi Kanagal-Shamanna, Director of the Molecular Diagnostic Lab at MD Anderson Cancer Center, will then present her lab’s experience using OGM with immunotherapies, focusing on CAR-T therapy. Don’t miss this opportunity to engage with these leading minds in the field and stay at the forefront of research advancements that are driving us closer to more effective and personalized cancer treatments.
A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.
Produced with support from:
Alex Hastie, PhD
VP, Clinical and Scientific Affairs
Bionano Genomics
Rashmi Kanagal-Shamanna, MD
Director, Molecular Diagnostic Lab
MD Anderson Cancer Center
The post The Emerging Role of Optical Genome Mapping in Immunotherapy Research appeared first on GEN – Genetic Engineering and Biotechnology News.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
